Mesenchymal Stem Cells Induce Directional Migration of Invasive Breast Cancer Cells through TGF-β

Scientific Reports

Volumn 5, Issue , 2015, Pages

  McAndrews, Kathleen M ^a   McGrail, Daniel J ^a   Ravikumar, Nithin ^a   Dawson, Michelle R ^a,b  

^a Georgia Institute of Technology   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONDITIONED MEDIUM; ENZYME INHIBITOR; FOCAL ADHESION KINASE 1; MATRIX METALLOPROTEINASE; PTK2 PROTEIN, HUMAN; RHO KINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANTAGONISTS AND INHIBITORS; BREAST TUMOR; CELL CULTURE; CELL CULTURE TECHNIQUE; CELL MOTION; COCULTURE; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; MCF-7 CELL LINE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHARMACOLOGY; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE; TUMOR INVASION;

BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; ENZYME INHIBITORS; FEMALE; FOCAL ADHESION KINASE 1; HUMANS; MATRIX METALLOPROTEINASES, SECRETED; MCF-7 CELLS; MESENCHYMAL STROMAL CELLS; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RHO-ASSOCIATED KINASES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84947560004     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16941     Document Type: Article

References (64)

1. Butcher, D. T., Alliston, T., Weaver, V. M. A tense situation: forcing tumour progression. Nat. Rev. Cancer 9, 108-22 (2009).
2. Albini, A., Sporn, M. B. The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer 7, 131-139 (2007).
3. Balkwill, F. R., Capasso, M., Hagemann, T. The tumor microenvironment at a glance. J. Cell Sci. 125, 5591-6 (2012).
4. Joyce, J. A. Therapeutic targeting of the tumor microenvironment. Cancer Cell 7, 513-20 (2005).
5. Kalluri, R., Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer 6, 392-401 (2006).
6. Kidd, S. et al. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One 7, e30563 (2012).
7. McGrail, D. J., Ghosh, D., Quach, N. D., Dawson, M. R. Differential mechanical response of mesenchymal stem cells and fibroblasts to tumor-secreted soluble factors. PLoS One 7, e33248 (2012).
8. McGrail, D. J., McAndrews, K. M., Dawson, M. R. Biomechanical analysis predicts decreased human mesenchymal stem cell function before molecular differences. Exp. Cell Res. 319, 684-96 (2013).
9. Calon, A. et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat. Genet. 47, 320-329 (2015).
10. Spaeth, E. L. et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4, e4992 (2009).
11. Karnoub, A. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557-563 (2007).
12. Cuiffo, B. G. et al. MSC-Regulated MicroRNAs Converge on the Transcription Factor FOXP2 and Promote Breast Cancer Metastasis. Cell Stem Cell 15, 762-774 (2014).
13. Chaturvedi, P. et al. Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. 123, 189-205 (2013).
14. Oskarsson, T. Extracellular matrix components in breast cancer progression and metastasis. The Breast 22 Suppl 2, S66-72 (2013).
15. Provenzano, P. P., Inman, D. R., Eliceiri, K. W., Keely, P. J. Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene 28, 4326-4343 (2009).
16. Ioachim, E. et al. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur. J. Cancer 38, 2362-2370 (2002).
17. Harvey, A., Yen, T.-Y., Aizman, I., Tate, C., Case, C. Proteomic Analysis of the Extracellular Matrix Produced by Mesenchymal Stromal Cells: Implications for Cell Therapy Mechanism. PLoS One 8, e79283 (2013).
18. Oskarsson, T. et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med 17, 867-874 (2011).
19. Ishihara, A., Yoshida, T., Tamaki, H., Sakakura, T. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin. Cancer Res. 1, 1035-1041 (1995).
20. Levental, K. R. et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906 (2009).
21. Paszek, M. J. et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241-54 (2005).
22. Calvo, F. et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat. Cell Biol. 15, 637-646 (2013).
23. Wolf, K. et al. Compensation mechanism in tumor cell migration: Mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 160, 267-277 (2003).
24. Wolf, K. et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat. Cell Biol. 9, 893-904 (2007).
25. Sahai, E., Marshall, C. J. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat. Cell Biol. 5, 711-719 (2003).
26. Zaman, M. H. et al. Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc. Natl. Acad. Sci. 103, 10889-10894 (2006).
27. Friedl, P., Wolf, K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3, 362-74 (2003).
28. Gaggioli, C. et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat. Cell Biol. 9, 1392-400 (2007).
29. Shieh, A. C., Rozansky, H. A., Hinz, B., Swartz, M. A. Tumor cell invasion is promoted by interstitial flow-induced matrix priming by stromal fibroblasts. Cancer Res. 71, 790-800 (2011).
30. Covas, D. T. et al. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp. Hematol. 36, 642-54 (2008).
31. Haniffa, M. A. et al. Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells. J. Immunol. 179, 1595-1604 (2007).
32. Friedl, P., Alexander, S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147, 992-1009 (2011).
33. Wirtz, D., Konstantopoulos, K., Searson, P. C. The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nat. Rev. Cancer 11, 512-22 (2011).
34. Carvalho, I., Milanezi, F., Martins, A., Reis, R. M., Schmitt, F. Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. Breast Cancer Res. 7, R788-95 (2005).
35. Bando, H. et al. Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer. Br. J. Cancer 92, 553-61 (2005).
36. Imamura, T., Hikita, A., Inoue, Y. The roles of TGF-signaling in carcinogenesis and breast cancer metastasis. Breast Cancer 19, 118-24 (2012).
37. Polyak, K. Heterogeneity in breast cancer. J. Clin. Invest. 121, 3786-3788 (2011).
38. Fraley, S. I. et al. A distinctive role for focal adhesion proteins in three-dimensional cell motility. Nat. Cell Biol. 12, 598-604 (2010).
39. Amano, M. et al. Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase). J. Biol. Chem. 271, 20246-20249 (1996).
40. Sulzmaier, F. J., Jean, C., Schlaepfer, D. D. FAK in cancer: mechanistic findings and clinical applications. Nat. Rev. Cancer 14, 598-610 (2014).
41. Klopp, A. H., Gupta, A., Spaeth, E., Andreeff, M., Marini, F. Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth. Stem Cells 29, 11-9 (2011).
42. Rape, A., Guo, W., Wang, Y. Microtubule depolymerization induces traction force increase through two distinct pathways. J. Cell Sci. 124, 4233-4240 (2011).
43. Pirone, D. M. et al. An inhibitory role for FAK in regulating proliferation: A link between limited adhesion and RhoA-ROCK signaling. J. Cell Biol. 174, 277-288 (2006).
44. Wang, H., Radjendirane, V., Wary, K. K., Chakrabarty, S. Transforming growth factor beta regulates cell-cell adhesion through extracellular matrix remodeling and activation of focal adhesion kinase in human colon carcinoma Moser cells. Oncogene 23, 5558-5561 (2004).
45. Sieg, D. J. et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2, 249-256 (2000).
46. Zhang, Y. et al. A role for focal adhesion kinase in hyluronan-dependent MMP-2 secretion in a human small-cell lung carcinoma cell line, QG90. Biochem. Biophys. Res. Commun. 290, 1123-1127 (2002).
47. Wang, M. et al. Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall. Arterioscler. Thromb. Vasc. Biol. 26, 1503-1509 (2006).
48. Poincloux, R. et al. Contractility of the cell rear drives invasion of breast tumor cells in 3D Matrigel. Proc. Natl. Acad. Sci. 108, 1943-1948 (2011).
49. Provenzano, P. P., Inman, D. R., Eliceiri, K. W., Trier, S. M., Keely, P. J. Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCK-dependent matrix reorganization. Biophys. J. 95, 5374-5384 (2008).
50. Ghosh, D. et al. Integral Role of Platelet Derived Growth Factor in Mediating Transforming Growth Factor-1 Dependent Mesenchymal Stem Cell Stiffening. Stem Cells Dev. 23, 245-261 (2013).
51. Mishra, P. J. et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 68, 4331-9 (2008).
52. Wipff, P. J., Rifkin, D. B., Meister, J. J., Hinz, B. Myofibroblast contraction activates latent TGF-1 from the extracellular matrix. J. Cell Biol. 179, 1311-1323 (2007).
53. Hawkins, P. T. et al. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. Curr. Biol. 5, 393-403 (1995).
54. Doanes, A. M., Irani, K., Goldschmidt-Clermont, P. J., Finkel, T. A requirement for Rac1 in the PDGF-stimulated migration of fibroblasts and vascular smooth cells. Biochem. Mol. Biol. Int. 45, 279-287 (1998).
55. Kalluri, R., Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428 (2009).
56. McAndrews, K. M., Yi, J., McGrail, D. J., Dawson, M. R. Enhanced Adhesion of Stromal Cells to Invasive Cancer Cells Regulated by Cadherin 11. ACS Chem. Biol. (2015). doi: 10.1021/acschembio.5b00353.
57. Martin, F. T. et al. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res. Treat. 124, 317-26 (2010).
58. Cufí, S. et al. Metformin against TGF-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to agingassociated fibrosis. Cell Cycle 9, 4461-4468 (2010).
59. Chaffer, C. L. et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154, 61-74 (2013).
60. McAndrews, K. M., Kim, M. J., Lam, T. Y., McGrail, D. J., Dawson, M. R. Architectural and Mechanical Cues Direct Mesenchymal Stem Cell Interactions with Crosslinked Gelatin Scaffolds. Tissue Eng. Part A 20, 3252-3260 (2014).
61. Crocker, J. C., Grier, D. G. Methods of Digital Video Microscopy for Colloidal Studies. J. Colloid Interface Sci. 310, 298-310 (1996).
62. McGrail, D. J., Kieu, Q. M. N., Dawson, M. R. The malignancy of metastatic ovarian cancer cells is increased on soft matrices through a mechanosensitive Rho-ROCK pathway. J. Cell Sci. 127, 2621-6 (2014).
63. McGrail, D. J. et al. Alterations in Ovarian Cancer Cell Adhesion Drive Taxol Resistance by Increasing Microtubule Dynamics in a FAK-dependent Manner. Sci. Rep. 5, 9529 (2015).
64. Toth, M., Fridman, R. Assessment of Gelatinases (MMP-2 and MMP-9) by Gelatin Zymography. Methods Mol. Med. 57, 10.1385/1-59259-136-1:163 (2001).